"pegylated-interferon-alpha-2b"

Zydus has received restricted emergency use approval from DCGI for the use of 'Virafin', PegIFN in treating moderate COVID-19 infection in adults

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India.